Full Text View
Tabular View
No Study Results Posted
Related Studies
Orally Active, Small Molecule Inhibitor of MEK1 and MEK2 in Patients With Active Rheumatoid Arthritis
This study has been completed.
Study NCT00650767   Information provided by Array BioPharma
First Received: March 31, 2008   Last Updated: July 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Rheumatoid Arthritis
Additional conditions recognized in this trial
Arthritis
Arthritis, Rheumatoid
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
ARRY-438162
Placebo
Sponsors listed in this trial
Array BioPharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services